Skip to content
Screener

Onto Innovation ONTO Business Segments — Other Nonoperating Income Expense

Similar metrics at other companies

Capricor Therapeutics logo
CAPRSingle Reportable — Other Nonoperating Income Expense
-$73K+47.2%
Theravance Biopharma logo
TBPHSingle Reportable — Other Nonoperating Income Expense
$3.01M+221%
Ur-Energy logo
URGSingle Reportable — Other Nonoperating Income Expense
$741K+2,750%
Norwegian Cruise Line Holdings Ltd. logo
NCLHSingle Reportable — Other Nonoperating Income Expense
$40.7M+266%
Scholar Rock logo
SRRKSingle Reportable — Other Nonoperating Income Expense
$995K+148%
XOM
XOMASingle Reportable — Other Nonoperating Income Expense
$4.72M+5,069%

Other financials

Income statement

See full
Revenue$343.1M+35.3%
Gross profit$183.3M+50.1%
Operating income$63.6M+97.1%
Net income$60.1M+75.8%
EPS (diluted)$1.21+75.4%

Balance sheet

See full
Cash & equivalents$1.3B+476%
Total debt$17.5M+15.3%
Total equity$1.9B-2.1%
Total assets$3.7B+72.8%

Cash flow

See full
Operating cash flow$61.5M+6.2%
CapEx$3.7M-73.4%
Free cash flow$57.9M+31.0%

Valuation

See full
Market cap$13.73B+212%
P/E84.6×+58.6×
P/S12.3×+8.0×

Profitability

See full
Gross margin50.4%-1.2pp
Operating margin12%-6.4pp
Net margin14.5%-1.8pp
FCF margin22.5%-0.5pp

Returns & leverage

See full
Return on equity8.3%-0.6pp
Debt / equity0.0×
Current ratio9.7×+0.1×

Where this comes from

Reported directly by Onto Innovation in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Onto Innovation’s 10-K, filed February 24, 2026.

Filed
Feb 24, 2026, 4:04 PM EST
Fiscal year
FY2025
Accession
0001193125-26-066937
Line itemYear Ended / January 3,2026Year Ended / December 28,2024Year Ended / December 30,2023
Amortization39,40949,43754,823
Operating income132,927187,103116,078
Interest income, net34,97133,48920,356
Other expense, net(4,996)(145)(3,852)
Provision for income taxes26,14318,77711,423
Net income$136,759$201,670$121,159
(1) Excludes restructuring and other expenses and merger and acquisition related expenses
(2) Excludes merger and acquisition related expenses

Item 16. Form 10-K Summary.

FAQ

What is Onto Innovation's business segments — other nonoperating income expense?
Onto Innovation (ONTO) reported business segments — other nonoperating income expense of -$1.25M in Q4 2025.
How has Onto Innovation's business segments — other nonoperating income expense changed year-over-year?
Onto Innovation's business segments — other nonoperating income expense decreased by 3345.5% year-over-year, from -$36.25K to -$1.25M.
What is the long-term trend for Onto Innovation's business segments — other nonoperating income expense?
Over 3 years (2022 to 2025), Onto Innovation's business segments — other nonoperating income expense has grown at a 228.4% compound annual growth rate (CAGR), from -$141K to -$5M.
What does business segments — other nonoperating income expense mean?
This metric captures miscellaneous income or expenses that are not directly related to the company's primary business operations, such as foreign exchange gains or losses, asset disposals, or other non-recurring financial items. It serves as a catch-all for financial impacts that fall outside of standard operating income and interest-related activities. Investors track this to identify one-time events that may distort the underlying performance of the core business.

Ask your AI about Onto Innovation's business segments — other nonoperating income expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude